Abstract:Results from previous studies on the role of autophagy of β‐cell function together with its implication in the development of diabetes are discussed. As β‐cell failure is an ultimate cause of diabetes and also that of unresponsiveness to the conventional therapy, modulation of β‐cell autophagy could be a future antidiabetic modality, particularly for patients who are not well managed with current antidiabetic therapy. Elucidating the molecular mechanism of autophagy was a landmark in understanding not only the physiology of cells and tissues, but also the pathogenesis of diverse diseases, including diabetes and metabolic disorders. Autophagy of pancreatic β‐cells plays a pivotal role in the maintenance of the mass, structure and function of β‐cells, whose dysregulation can lead to abnormal metabolic profiles or diabetes. Modulators of autophagy are being developed to improve metabolic profile and β‐cell function through the removal of harmful materials and rejuvenation of organelles, such as mitochondria and endoplasmic reticulum. Among the known antidiabetic drugs, glucagon‐like peptide‐1 receptor agonists enhance the autophagic activity of β‐cells, which might contribute to the profound effects of glucagon‐like peptide‐1 receptor agonists on systemic metabolism. In this review, the results from studies on the role of autophagy in β‐cells and their implication in the development of diabetes are discussed. In addition to non‐selective (macro)autophagy, the role and mechanisms of selective autophagy and other minor forms of autophagy that might occur in β‐cells are discussed. As β‐cell failure is the ultimate cause of diabetes and unresponsiveness to conventional therapy, modulation of β‐cell autophagy might represent a future antidiabetic treatment approach, particularly in patients who are not well managed with current antidiabetic therapy.

Research progress on the relationship between autophagy and chronic complications of diabetes

The Role of Autophagy of Endothelial Cells in Diabetic Vascular Diseases

Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential

Research progress of autophagy in diabetic kidney disease pathogenesis

Research progress of autophagy in pathogenesis of diabetes nephropathy

Research Progress of Autophagy and Diabetic Retinopathy

The role of glucagon-like peptide-1/GLP-1R and autophagy in diabetic cardiovascular disease

The role of autophagy in the treatment of type II diabetes and its complications: a review

Redefining the Role of Autophagy in Diabetic Vascular Diseases

The critical role of dysregulated autophagy in the progression of diabetic kidney disease

Physiological and pathological characteristics of vascular endothelial injury in diabetes and the regulatory mechanism of autophagy

The relationship between HMGB1 and autophagy in the pathogenesis of diabetes and its complications

Autophagy and Diabetic Encephalopathy: Mechanistic Insights and Potential Therapeutic Implications

Dysregulated autophagy: A key player in the pathophysiology of type 2 diabetes and its complications

5'-Monophosphate-activated protein kinase (AMPK) improves autophagic activity in diabetes and diabetic complications

Autophagy in diabetes: β-cell dysfunction, insulin resistance, and complications

Research advance in autophagy in obesity

Targeting autophagy with natural products as a potential therapeutic approach for diabetic microangiopathy

Autophagy-nutrient sensing pathways in diabetic complications

Targeting Autophagy: A Promising Therapeutic Strategy for Diabetes Mellitus and Diabetic Nephropathy

Role of β‐cell autophagy in β‐cell physiology and the development of diabetes